Published online October 1, 2008
PEDIATRICS Vol. 122 No. 4 October 2008, pp. 866-868 (doi:10.1542/peds.2007-3142)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marks, K.
Right arrow Articles by Squires, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, K.
Right arrow Articles by Squires, J. K.
Related Collections
Right arrow Office Practice
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

COMMENTARY

The Thorny Nature of Predictive Validity Studies on Screening Tests for Developmental-Behavioral Problems

Kevin Marks, MDa, Frances Page Glascoe, PhDb, Glen P. Aylward, PhDc, Michael I. Shevell, MDd, Paul H. Lipkin, MDe,f and Jane K. Squires, PhDg

a Department of Pediatrics, PeaceHealth Medical Group, Eugene, Oregon
b Department of Pediatrics, Vanderbilt University, Nashville, Tennessee
c School of Medicine, Southern Illinois University, Springfield, Illinois
d Departments of Neurology/Neurosurgery and Pediatrics, McGill University, Montreal, Quebec, Canada
e Division of Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, Maryland
f Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
g College of Education, University of Oregon, Eugene, Oregon

The first 20% of the full text of this article appears below.

Over the last few years, several researchers have focused on the predictive validity of developmental-behavioral screening tools.1–11 Predictive validity studies compare the results of a screening test administered at a single point in time (referred to hereafter as time 1) to the results of a diagnostic test or battery administered 3 months to several years later (time 2).12 Unlike concurrent validity studies in which both screening and diagnostic measures are administered at the same time to determine the sensitivity and specificity of a screen, predictive validity studies depend on longitudinal measurement and focus on how well a screen predicts future developmental status. As a consequence, predictive validity research offers a critical illustration of whether a screening test measures dimensions of development that are enduring and have a meaningful impact on children's long-term outcomes. As already stated by the American Academy of Pediatrics, a concerning, high-quality screening result should generate a referral to early intervention or special education, which has been shown to improve a child's developmental, behavioral, and/or school-readiness trajectory.9, 13–17

Nevertheless, predictive validity studies on screening tests are also fraught with challenges, particularly because young children change rapidly. For example, at 18 months some children may not be talking much. By 24 months we expect much more. Some children who seemed fine at 18 months have begun to have trouble (eg, combining words). Others will have had the benefit of intervention and overcome earlier deficits. The adverse impact of psychosocial risk becomes more apparent with age. Developmental functions can be emergent, latent (not yet measurable), delayed, deficient, or disordered.13 Measuring the moving target that is child development is not impossible, but it is one of the reasons that professional organizations such as the American Academy of Pediatrics recommend ongoing surveillance at each . . . [Full Text of this Article]

Address correspondence to Frances Page Glascoe, PhD, 25 Bragg Dr, East Berlin, PA 17316. E-mail: frances.p.glascoe@vanderbilt.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?